Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
-Presbyterian Hospital are recruiting for a Hospitalist in the Division of Pediatric Hematology, Oncology and Stem Cell Transplantation The successful candidate will have the opportunity to collaborate with
-
of these conditions and find better treatment options for patients with movement disorders. Our researchers are involved in preclinical and clinical research studying possible therapeutics including stem cell therapy
-
to complete the final exam. Desired qualifications: Background in cell or developmental biology, stem cell biology, or neuroscience Hands-on experience with human pluripotent stem cells, 3D cell culture systems
-
experience delayed or incomplete tissue repair, including poor bone healing.1 Current therapeutic strategies rely on controlling stem cell differentiation and macrophage polarization towards pro-/anti
-
, and Math (STEM) Development, Identity, and Vision (STEMDIV) Research Programs at the University of California, Santa Cruz (UCSC) invites applications for scholars to participate in the NIH
-
, contributing to study design, and assisting with the development of manuscripts, grant applications, and reports. This position provides the opportunity to apply advanced skills in stem cell biology and
-
tissue and stem-cell based models of the developing human brain. Applicants with a PhD in a biological discipline with wet lab experience running sequencing based genomics assays are encouraged to apply
-
Center for Advancement of Blood Cancer Therapies (CABCT) (https://icahn.mssm.edu/research/cabct ). The successful candidate will work on projects involving human induced pluripotent stem cells (iPSCs) and
-
well as at the Faculty of Health and Medical Sciences: https://healthsciences.ku.dk/research/corefacilities/. Driving Discoveries towards Stem Cell-Based Therapies and Regenerative Medicine reNEW is committed
-
Summary: Our lab aims to understand the mechanisms underlying metabolic remodeling and cardiac fibrosis in hypertrophic cardiomyopathy (HCM), using mouse models and human induced pluripotent stem cells